Alzheimer’s Disease Linked to Disrupted Internal Clock, Offering New Treatment Pathways
Table of Contents
A groundbreaking study published October 23 in Nature Neuroscience reveals a strong connection between Alzheimer’s disease and the body’s circadian rhythm, potentially opening new avenues for treatment and prevention. Researchers have discovered that the disease disrupts the internal biological clock within specific brain cells, altering gene activity and accelerating cognitive decline.
Difficulty sleeping, restlessness, and daytime napping are often early indicators of Alzheimer’s, while later stages can bring on increased confusion and agitation – a phenomenon known as “sundowning.” These patterns have long suggested a link to the circadian system, which governs sleep-wake cycles and other vital bodily functions. However, the extent of this connection remained unclear until now.
The Circadian Rhythm’s Role in Alzheimer’s Progression
A research team at Washington University School of Medicine in St. Louis demonstrated in mouse models that Alzheimer’s disease directly impacts circadian rhythms within brain cells. This disruption doesn’t simply affect sleep; it fundamentally alters how and when hundreds of genes are activated and deactivated, impacting crucial brain functions.
“There are 82 genes that have been associated with Alzheimer’s disease risk, and we found that the circadian rhythm is controlling the activity of about half of those,” explained a senior researcher involved in the study. “Knowing that a lot of these Alzheimer’s genes are being regulated by the circadian rhythm gives us the opportunity to find ways to identify therapeutic treatments to manipulate them and prevent the progression of the disease.”
Sleep Disruption: A Key Early Warning Sign
Disturbed sleep is a frequent complaint from caregivers of Alzheimer’s patients, and previous research from the team showed that these sleep changes can begin years before noticeable memory loss. Beyond the exhaustion experienced by both patients and caregivers, these disruptions create stress that may exacerbate the disease’s progression. Identifying the root cause of these sleep disturbances is therefore critical.
The body’s circadian system regulates approximately 20% of all genes in the human genome, orchestrating essential processes like digestion, immune response, and, of course, sleep-wake cycles. Restoring balance to this system could be a powerful therapeutic strategy.
Amyloid Plaques and the Brain’s Internal Timing
Earlier work by the research team identified a protein called YKL-40 that fluctuates throughout the day and helps regulate amyloid levels in the brain. Elevated levels of YKL-40, linked to Alzheimer’s risk, can trigger the buildup of amyloid – a sticky protein that forms plaques, a hallmark of the disease.
Because Alzheimer’s symptoms often follow a daily pattern, researchers suspected that other circadian-regulated proteins and genes were involved. To investigate, they examined gene activity in the brains of mice with amyloid buildup, comparing them to healthy young mice and older mice without plaques, collecting samples every two hours over a 24-hour period.
The findings revealed that amyloid deposits disrupted the normal rhythm of hundreds of genes in two key brain cell types: microglia and astrocytes. Microglia act as the brain’s immune cells, clearing away waste and harmful materials, while astrocytes support neuron communication and maintain healthy brain function. Critically, many of the affected genes are responsible for microglia’s ability to remove waste, including amyloid.
While these genes weren’t entirely switched off, their timing and order became chaotic, weakening the brain’s ability to clear toxins. The study also showed that amyloid plaques created new rhythmic patterns in genes not normally subject to daily cycles, many of which are involved in inflammation and the brain’s stress response.
Potential for Targeted Therapies
These discoveries suggest that therapies aimed at adjusting circadian rhythms in microglia and astrocytes could promote healthier brain activity.
“We have a lot of things we still need to understand, but where the rubber meets the road is trying to manipulate the clock in some way, make it stronger, make it weaker or turn it off in certain cell types,” the lead researcher stated. “Ultimately, we hope to learn how to optimize the circadian system to prevent amyloid accumulation and other aspects of Alzheimer’s disease.”
This research was supported by the National Institute on Aging (R01AG054517, T32AG058518), the National Institute of Neurological Disorders and Stroke (R01NS102272), and the National Institutes of Health (R00AG061231). The authors note that the content reflects their findings and does not necessarily represent the official view of the NIH.
